Everything by David.

Investing

Avis Rockets 15% Even as Barclays Downgrades Into the Face of a Parabolic Rally

Apr 21, 2026 Investing

Lucid Climbs 8% on PIF Takeover Chatter: Can Speculation Overcome Execution Concerns?

Apr 21, 2026 Investing

Trade Desk Rallies 7% Despite Jefferies Caution: Is the AI Ad Growth Story Still Intact?

Apr 20, 2026 Investing

Plug Power Jumps 10% on Contract Win and Investor Outreach as Hydrogen Comeback Continues

Apr 20, 2026 Investing

Avis Surges 11% as Shorts Can’t Cover: Parabolic Blow-Off or Generational Squeeze?

Apr 20, 2026 Investing

Lucid Drops 5% Into New Lows: Could the Free-Fall Itself Trigger a Buyout Catalyst?

Apr 20, 2026 Investing

BlackBerry Surges 15% on NVIDIA Deal: Is the Long-Awaited Revaluation Finally Here?

Apr 20, 2026 Investing

William Blair Initiates Cameco at Outperform With $165 Fair Value: Is Uranium Entering a Supercycle?

Apr 20, 2026 Investing

Northland Crowns IonQ Best-in-Class Quantum Stock With a $55 Target: Is the Supercycle Here?

Apr 20, 2026 Investing

Wedbush Projects $90 for MP Materials: Is This the Only Real Play on American Rare Earth Independence?

Apr 20, 2026 Investing

Amazon Gets a Double Upgrade From BofA and KeyBanc Ahead of Earnings: Is $325 the New Floor?

Apr 20, 2026 Investing

Wells Fargo Upgrades Biogen to Overweight: Does the Alzheimer’s Story Finally Have a Second Act?

Apr 20, 2026 Investing

BofA Trims Meta Platforms Price Target to $820 but Stays Bullish: Is Ad Spending Holding Up Better Than Feared?

Apr 20, 2026 Investing

Mizuho Raises Robinhood to $115 as the SEC Pattern Day Trader Rule Change Opens the Floodgates

Apr 20, 2026 Investing

Jefferies Upgrades Ulta Beauty to Buy With a $700 Target: Is the Beauty Cycle Roaring Back?

Apr 20, 2026 Investing

Stifel Just Hiked Intel’s Target From $42 to $65: Has the Comeback Finally Arrived?

Apr 20, 2026 Investing

Stifel Raises AMD Target to $320: Is the AI Chip Rally Just Getting Started?

Apr 20, 2026 Investing

Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal

Apr 20, 2026 Investing

Cleveland-Cliffs Drops 5% Despite Narrower-Than-Expected Q1 Loss as Strategic Doubts Resurface

Apr 20, 2026 Investing

AST SpaceMobile Dives 10% on Launch Failure, but Manufacturing Pipeline Offers a Path to Recovery

Apr 20, 2026